Literature DB >> 7632534

Intraperitoneal erythropoietin treatment of children with chronic renal failure.

B T Steele1, A Vigneux.   

Abstract

Intraperitoneal erythropoietin was given to three children on chronic peritoneal dialysis. Doses between 100 and 150 units/kg were given undiluted into a dry cavity twice weekly and left for 10-12 h before resuming dialysis. Satisfactory haemoglobin levels were seen over a 6-month period and there were no complications. Intraperitoneal administration of erythropoietin is cost-effective and avoids the local pain of subcutaneous injections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632534     DOI: 10.1007/bf02254214

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  Erythropoietin and peritoneal dialysis: the efficacy of intraperitoneal dosing.

Authors:  A R Nissenson
Journal:  Perit Dial Int       Date:  1992       Impact factor: 1.756

2.  Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis.

Authors:  L A Frenken; H J van Lier; P G Gerlag; M den Hartog; R A Koene
Journal:  BMJ       Date:  1991-08-03

3.  Identification of the component part in an epoetin alfa preparation that causes pain after subcutaneous injection.

Authors:  L A Frenken; H J van Lier; J G Jordans; K M Leunissen; R van Leusen; V M Verstappen; R A Koene
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

4.  Experience of pain after subcutaneous administration of different preparations of recombinant human erythropoietin: a randomized, double-blind crossover study.

Authors:  C Granolleras; W Leskopf; S Shaldon; J Fourcade
Journal:  Clin Nephrol       Date:  1991-12       Impact factor: 0.975

5.  Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.

Authors:  S F Lui; C B Law; S M Ting; P Li; K N Lai
Journal:  Clin Nephrol       Date:  1991-11       Impact factor: 0.975

6.  Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis.

Authors:  R E Reddingius; C H Schröder; L A Monnens
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

7.  The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate.

Authors:  J M Bargman; J E Jones; J M Petro
Journal:  Perit Dial Int       Date:  1992       Impact factor: 1.756

8.  Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.

Authors:  A Ateshkadi; C A Johnson; L L Oxton; T G Hammond; W S Bohenek; S W Zimmerman
Journal:  Am J Kidney Dis       Date:  1993-06       Impact factor: 8.860

  8 in total
  1 in total

Review 1.  Use of erythropoiesis-stimulating agents in children with chronic kidney disease: a systematic review.

Authors:  Gordon Bruce; Peter Schulga; Ben C Reynolds
Journal:  Clin Kidney J       Date:  2022-02-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.